与此同时,该公司在周二收盘后表示,Idera 不再招募患者进入 tilsotolimod 与 BMS的 Yervoy 和 ...查看全文
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003298 Size: 55 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003297 Size: 80 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003296 Size: 55 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003295 Size: 58 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003294 Size: 80 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003242 Size: 1 MB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003241 Size: 54 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003202 Size: 54 KB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003201 Size: 1 MB 网页链接
$井寺制药(IDRA)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-22 AccNo: 0001104659-18-003201 Size: 1 MB 网页链接